Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EI24
Introduction
Etoposide-induced protein 2.4 homolog is a protein that in humans is encoded by the EI24 gene.[1][2][3]
This gene has higher expression in p53-expressing cells than in control cells and is an immediate-early induction target of p53-mediated apoptosis. The protein encoded by this gene contains six putative transmembrane domains and may suppress cell growth by inducing apoptotic cell death through the caspase 9 and mitochondrial pathways. This gene is located on human chromosome 11q24, a region frequently altered in cancers. Alternative splicing results in two transcript variants encoding different isoforms.[3]
References
References
- ↑ Gu Z, Flemington C, Chittenden T, Zambetti GP (Jan 2000). “ei24, a p53 response gene involved in growth suppression and apoptosis”. Mol Cell Biol. 20 (1): 233–41. doi:10.1128/MCB.20.1.233-241.2000. PMC 85079. PMID 10594026.
- ↑ Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (Sep 1997). “A model for p53-induced apoptosis”. Nature. 389 (6648): 300–5. doi:10.1038/38525. PMID 9305847.
- ↑ 3.0 3.1 “Entrez Gene: EI24 etoposide induced 2.4 mRNA”.
Further reading
Further reading
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Gu Z, Gilbert DJ, Valentine VA, et al. (2000). “The p53-inducible gene EI24/PIG8 localizes to human chromosome 11q23 and the proximal region of mouse chromosome 9”. Cytogenet. Cell Genet. 89 (3–4): 230–3. doi:10.1159/000015620. PMID 10965130.
- Burns TF, Bernhard EJ, El-Deiry WS (2001). “Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo”. Oncogene. 20 (34): 4601–12. doi:10.1038/sj.onc.1204484. PMID 11498783.
- Gentile M, Ahnström M, Schön F, Wingren S (2002). “Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis”. Oncogene. 20 (53): 7753–60. doi:10.1038/sj.onc.1204993. PMID 11753653.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.